Health Atlas中文

RESEARCH LESSON / Longer life, clearer questions

Biological age: an estimate with a training target

Epigenetic clocks summarize patterns in DNA methylation. Their outputs can be useful for research, but a change in an estimate is not automatically a change in lifespan.

Natural tree growth rings, an olive shoot and a glass hourglass on dark stone steps.
AI-generated conceptual illustration
Learn / Longer life, clearer questions / 10 in this path

START WITH THE ANSWER

If a biological-age test falls by three years, did someone gain three years of life?

No. A clock estimates a particular pattern against its training data. It must be validated for the proposed use, and a treatment-induced change needs separate evidence linking it to meaningful health outcomes.

01

The first question is what the model learned

Horvath's 2013 multi-tissue clock used DNA-methylation data from about 8,000 samples across 51 healthy tissues and cell types. Its final predictor combined information from 353 CpG sites. DNA methylation is a chemical marking pattern on DNA; the model turns selected measurements into an age estimate. A predictor trained to resemble chronological age is answering a different question from a model trained on mortality risk or the rate of physiological change. Calling all three “biological age” can hide those differences. A blood-based result also should not be casually treated as a direct measurement of every organ's condition. The algorithm, sample type and target remain part of the meaning of the number.

02

One intervention did not move all clocks alike

A 2023 post hoc CALERIE analysis examined DNA-methylation measures after two years of calorie restriction. The DunedinPACE measure changed in a direction interpreted as roughly 2–3% slower pace of aging, while the PhenoAge and GrimAge measures did not show the same significant intervention effect. DunedinPACE represents a rate, whereas the other outputs summarize accumulated age-related patterns. The difference is not a minor naming issue: a rate and an accumulated state need not respond on the same timescale. The trial did not follow participants until death to verify a lifespan gain. Its biomarker result is therefore a research finding about those measures under that intervention, not a conversion table from restriction to extra years.

03

A younger estimate can leave an important question unanswered

Suppose a fictional program reports a lower clock estimate but does not measure walking ability, symptoms or disease events. The result could be scientifically interesting while leaving the participant's most important goal unresolved. Conversely, someone who regains the ability to visit friends has a concrete functional gain even if a clock barely moves. WHO's focus on functional ability helps keep these outcomes visible. For evaluating a commercial test, the useful details include which version is used, which sample is collected, how repeat measurements vary and what action the result is supposed to support. Repeating a test until the most flattering value appears does not demonstrate an intervention effect. Nor can a before-and-after testimonial separate the treatment from all the other changes that occurred between samples.

04

Label the units correctly

Compare three imaginary labels: “estimated age in years,” “pace relative to a reference” and “risk of a specified event.” Explain why the values cannot be exchanged directly. For any claim of reversal, identify whether the evidence measured a clock, a functional outcome or survival.

What to take away

  • Clock names and training targets matter.
  • A biomarker change is not a measured extension of life.

CHECK YOUR UNDERSTANDING

Why is a slower pace estimate different from becoming younger?

Think it through, then reveal the explanation

A rate describes how fast a process is estimated to change; an age estimate describes an accumulated state, and neither alone proves added survival.

A learning question, not a health assessment. No answers are collected or saved.

Original material & reading scope

Observational Horvath: DNA methylation age of human tissues and cell types

Read indexed original abstract and figure descriptions; direct PubMed was empty. Algorithm development, not an intervention trial.

Checked 2026-09-21 · 2013

Open original source Lessons using this source
Trial Waziry et al.: Calorie restriction and DNA methylation measures of biological aging

Read indexed original abstract, results and algorithm descriptions; direct publisher returned an error. Post hoc analysis of CALERIE.

Checked 2026-09-21 · 2023

Open original source Lessons using this source
Official guidance WHO: Healthy ageing and functional ability

Read official Q&A on function, capacity, environment and diversity.

Checked 2026-09-21 · 2020

Open original source Lessons using this source
Longer life, clearer questionsFree lesson4 min · full lesson

Healthspan begins with what life can contain

Longer life, preserved ability and a younger laboratory estimate are different goals. A function-centered view connects longevity research to mobility, decisions, relationships and an accessible environment.

5 source recordsRead the lesson
Longer life, clearer questionsFree lesson3 min · full lesson

Preserving a 400-meter walk: the LIFE trial

A structured activity program reduced major mobility disability in older adults already at risk. The trial turns an abstract longevity ambition into a concrete question about continued movement.

3 source recordsRead the lesson